Background: Cyclins and cyclin-dependent kinases induce and coordinate the events of the cell cycle, although the mechanisms by which they do so remain largely unknown. In budding yeast, a pathway used by the Clb2 cyclin to control bud growth during mitosis provides a good model system in which to understand how cyclin-dependent kinases control cell-cycle events. In this pathway, Clb2 initiates a series of events that lead to the mitosis-specific activation of the Gin4 protein kinase. A protein called Nap1 is required in vivo for the activation of Gin4, and is able to bind to both Gin4 and Clb2. We have used a simple genetic screen to identify additional proteins that function in this pathway.
Background
The events of cell division are controlled by a family of proteins called cyclin-dependent kinases, which are activated at specific stages of the cell cycle when they bind to members of the cyclin family of proteins [1, 2] . Although considerable progress has been made towards understanding the regulation of cyclin-dependent kinases, we still know little about the molecular pathways used by these kinases to induce the actual events of cell division. Simple organisms use a single cyclin-dependent kinase to induce the events of both interphase and mitosis, demonstrating that the same cyclin-dependent kinase can induce different events when activated at different times during the cell cycle. We do not yet understand the molecular mechanisms that make such specificity possible.
The fact that cyclin-dependent kinases are bound to different cyclins at each stage of the cell cycle suggests that the cyclins function to determine the cell-cycle events induced by specific cyclin-dependent kinase complexes. In previous work we reasoned that in order for cyclins to confer this kind of specificity they must bind to specific proteins involved in the control of cell-cycle events, and we used affinity chromatography to search for such proteins [3] . This led to the identification of a highly conserved protein called Nap1 which binds specifically to mitotic cyclins in organisms as divergent as vertebrates and yeast. In budding yeast, Nap1 binds to the mitotic cyclin Clb2 and is required for the ability of Clb2 to induce specific mitotic events. One of these events is a switch in the pattern of bud growth that occurs as cells enter mitosis [4] . A newly formed bud initially grows only at its tip; however, during mitosis the Clb2-Cdc28 kinase complex causes bud growth to occur over the entire bud surface, leading to the formation of a round bud [5, 6] . Without Nap1, the Clb2-Cdc28 kinase complex is unable to induce this switch in the pattern of bud growth and the new bud therefore continues to grow at its tip during mitosis, giving rise to highly elongated buds [4] .
The pathway used by Clb2 to control bud growth during mitosis is not essential for viability, and cells with defects in this pathway can easily be identified in genetic screens because they give rise to colonies with a peculiar morphology [3, 4, 7] . This pathway therefore represents an ideal genetic model system in which to understand the mechanisms used by cyclin-dependent kinases to control specific cell-cycle events. By screening for mutations that disrupt the control of bud growth during mitosis, we identified a protein kinase called Gin4 [7] . The phenotype caused by deletion of the GIN4 gene is nearly identical to the phenotype caused by deletion of the NAP1 gene, and Gin4 binds tightly to Nap1. Furthermore, the kinase activity of Gin4 is specifically activated during mitosis in a Nap1-dependent manner [7] .
To learn more about the Clb2-dependent pathway that controls bud growth during mitosis, we have characterized a mutation that causes an elongated bud phenotype that closely resembles the phenotype caused by loss of function of Gin4 or Nap1 in cells that are dependent upon Clb2 for survival. These studies have demonstrated that the Cdc42 GTPase and a member of the PAK kinase family called Cla4 have important roles in the control of mitotic events by the Clb2 cyclin.
Results
Cla4, a member of the PAK kinase family, functions in a Clb2-dependent mitotic control pathway
In previous work we used a simple genetic screen to identify mutations that cause the formation of elongated buds due to a disruption of the control of polar bud growth during mitosis. This led to the identification of the Gin4 protein kinase, which has an important role in the control of mitotic events by Clb2 [7] . In the same genetic screen that identified Gin4, we isolated a mutation that causes an elongated bud phenotype that closely resembles the phenotype caused by deletion of the GIN4 gene or of the NAP1 gene (Figure 1) . We cloned the gene identified by this mutation and found that it encodes a previously identified member of the PAK kinase family called Cla4 [8] . Members of the PAK kinase family were first identified as proteins that bind specifically to the GTP-bound form of the Cdc42 GTPase, and members of the PAK kinase family have been implicated in such diverse events as actin cytoskeletal rearrangements, AIDS progression, and signaling by the ras oncogene [9] [10] [11] [12] [13] .
We found that deletion of the CLA4 gene causes an elongated bud phenotype that is identical to the phenotype of the mutation isolated in our screen. The elongated bud phenotype caused by loss of Cla4 function strongly suggested that Cla4 functions in the pathway used by Clb2, Nap1 and Gin4 to control bud growth during mitosis. To further test whether Cla4 functions in this pathway, we looked for genetic and functional interactions between Cla4 and the proteins known to function in the pathway. We first tested for genetic interactions between CLA4, GIN4 and NAP1. To do this, we constructed strains that carry a CLA4 gene deletion in combination with either a GIN4 or NAP1 gene deletion. In each case, we found that cells carrying the double deletion were barely viable when grown at 37°C, whereas cells carrying the single deletions formed colonies at a normal or nearly normal rates (Figure 2a ). These results demonstrate that Cla4, Gin4 and Nap1 are involved in related functions within the cell.
We next determined whether Cla4 interacts genetically with the mitotic cyclins. There are four mitotic cyclins in budding yeast, called Clb1, Clb2, Clb3 and Clb4. These cyclins are highly redundant, but cells can be made dependent upon the Clb2 cyclin for viability by deleting the genes for Clb1, Clb3 and Clb4 [14, 15] . This is referred to as a Clb2-dependent genetic background, and allows one to study pathways controlled by Clb2 without the complication of redundant pathways controlled by other mitotic cyclins. We had found previously that deletion of the genes for Gin4 or Nap1 in a Clb2-dependent background results in a much more severe phenotype than in a wild-type background, suggesting that Gin4 and Nap1 mediate Clb2-dependent functions [3, 7] . We tested whether the same is true for Cla4 by examining the phenotype of a CLA4 deletion in a wild-type and in a Clb2-dependent background. The phenotype of the ecm30 mutation identified in a screen for mutations that cause an elongated cell morphology [7] . The mutant strain shown here is in the Clb2-dependent strain background used for the original genetic screen [7] .
As with GIN4 and NAP1, we found that the elongated bud phenotype of a CLA4 deletion was significantly enhanced in the Clb2-dependent background (Figure 2b) . CLA4 is unique, however, in that deletion of the CLA4 gene produced a more severe phenotype in a wild-type background than does deletion of the genes for either GIN4 or NAP1. This might suggest that Cla4 also has a role in the pathways used by the other mitotic cyclins to control bud growth.
Previous work has demonstrated genetic and physical interactions between CLA4 and CDC42 [8, 16] . We therefore searched for genetic interactions between CDC42 and genes encoding proteins that function in the Clb2-dependent mitotic control pathway. We found that deletion of the NAP1 gene completely suppressed the temperature sensitivity of the cdc42-1 allele, whereas deletion of the GIN4 gene did not (Figure 2c ). These results suggest that Nap1 and Cdc42 are likely to function together within the cell, and they suggest that Nap1 may be a negative regulator of Cdc42.
Cla4 is required for the mitosis-specific activation of the Gin4 kinase
We next tested for functional interactions between Cla4 and Gin4. The Gin4 protein becomes hyperphosphorylated during mitosis, which leads to activation of Gin4 kinase activity [7] . Thus, the mitosis-specific activation of Gin4 can be conveniently detected by assaying for a hyperphosphorylation-induced shift in the electrophoretic mobility of Gin4 [7] . By assaying the mitosis-specific hyperphosphorylation of Gin4 in synchronized cultures of ∆cla4 cells, we found that Gin4 hyperphosphorylation was completely dependent upon Cla4 in vivo (Figure 3a) . Control experiments showed that the Clb2 protein appeared at the same time in wild-type and ∆cla4 cells, demonstrating that the defect in Gin4 activation is not due to failure of ∆cla4 cells to enter mitosis (Figure 3b ). Note that Clb2 protein levels remain high in the ∆cla4 cells, consistent with a prolonged mitotic delay. We have found that the Gin4 protein can be detected among the proteins that elute from a Cla4 affinity column, consistent with a functional relationship between Cla4 and Gin4 (data not shown). However, Gin4 is not among the major proteins that are easily visualized by Coomassie blue staining of the eluted fractions, and we therefore suspect that the interaction between Cla4 and Gin4 is either of low affinity or indirect.
Clb2 and the Cdc42 GTPase act synergistically to induce hyperphosphorylation of Cla4
To learn more about the role of the Cla4 protein in mitosis, we determined whether Cla4 undergoes mitosisspecific regulation. As a first step, we arrested cells in interphase or mitosis, and then used western blotting to This result raises two questions. First, why does only a fraction of Cla4 undergo hyperphosphorylation during mitosis? Also, what factors are responsible for inducing the mitosisspecific hyperphosphorylation of Cla4? To begin to answer these questions, we looked more closely at the regulation of Cla4 hyperphosphorylation. Cla4 is known to be activated in vitro by binding of the GTP-bound form of Cdc42 [8, 16] . It therefore seemed possible that hyperphosphorylation of Cla4 is the result of autophosphorylation induced by binding of the GTP-bound form of Cdc42 to Cla4. In addition, as Cla4 hyperphosphorylation is a mitosis-specific event and Cla4 shows genetic interactions with Clb2, it also seemed possible that the mitotic cyclin Clb2 may somehow have a role in Cla4 hyperphosphorylation. We therefore determined whether overexpression of Clb2 and/or the GTP-bound form of Cdc42 causes the hyperphosphorylation of Cla4. For these experiments, we used the conditional GAL10 promoter to express a mutant form of Cdc42 that is locked into the GTP-bound form (called Cdc42 V12 ) [17] . Similarly, we used the GAL1 promoter to express a version of Clb2 that lacks the 'destruction box' that targets Clb2 for destruction during interphase (called Clb2 ∆176 ), thereby allowing Clb2 to accumulate in cells during interphase [18] . Before inducing expression of Clb2 ∆176 or Cdc42 V12 , we arrested cells in interphase so that we could study the effects of these proteins under conditions where there are no other mitotic cyclins present. We found that expression of Clb2 ∆176 or Cdc42 V12 alone did not induce a major shift in the electrophoretic mobility of Cla4. Expression of the two proteins together, however, led to a rapid and dramatic electrophoretic mobility shift ( Figure 4b ). Treatment of Cla4 with phosphatase caused the electrophoretic mobility shift to disappear, demonstrating that it is due to hyperphosphorylation (Figure 4c ).
The wild-type version of Cdc42 was not capable of inducing Cla4 hyperphosphorylation, demonstrating that only the GTP-bound form of Cdc42 is able to induce this event ( Figure 4b ). Similarly, a non-degradable form of a related mitotic cyclin called Clb3 ∆46 was only able to induce weak hyperphosphorylation of Cla4, indicating that hyperphosphorylation is a Clb2-specific function rather than a result of arresting cells in mitosis ( Figure 4d ). Controls demonstrated that the non-degradable form of Clb3 was able to arrest cells in mitosis with large buds in the same manner as Clb2 (data not shown). The fact that only a fraction of Cla4 undergoes hyperphosphorylation during a normal cell cycle suggests either that hyperphosphorylation is a highly transient event, or that only a fraction of Cla4 is used during mitosis.
In previous work, we found that overexpression of a nondegradable form of Clb2 in cells arrested in interphase is able to induce hyperphosphorylation of Gin4 (see Figure 11 of Altman and Kellogg [7] ). In those studies however, we found that only a fraction of Gin4 is induced to undergo hyperphosphorylation by expression of Clb2, which we could detect on a long exposure of a western blot. We suspect that a small fraction of Gin4 is hyperphosphorylated in this situation because a fraction of the Cdc42 in the cell is transiently in the GTP-bound form. We only observe rapid and quantitative hyperphosphorylation of Gin4 when both Clb2 and the GTP-bound form of Cdc42 are expressed together.
The hyperphosphorylated form of Cla4 is likely to signal the activation of the Gin4 kinase
We next addressed the effect of expression of Clb2 ∆176 and Cdc42 V12 on Gin4 activation. As with Cla4 Cla4 is required for the mitosis-specific hyperphosphorylation of the Gin4 kinase. (a) Wild-type (WT) and ∆cla4 cells were synchronized in G1 by arrest with the mating pheromone α-factor and were then released from the arrest and allowed to progress through the cell cycle. At each of the indicated times, samples were taken and the hyperphosphorylation of Gin4 was assayed as previously described using an anti-Gin4 antibody as a probe [7] . Hyperphosphorylation is indicated by a shift in electrophoretic mobility of the Gin4 protein. hyperphosphorylation, we found that Gin4 became hyperphosphorylated only in the situation where Clb2 ∆176 and Cdc42 V12 were expressed together (Figure 5a ). Furthermore, we found that expression of Clb2 ∆176 and Cdc42 V12 together in a ∆cla4 strain did not lead to Gin4 hyperphosphorylation (Figure 5b ), consistent with our previous results demonstrating that the mitosis-specific activation of Gin4 required Cla4 (see Figure 3a) . These results provide further evidence that Cla4 is required for activation of the Gin4 kinase, and they argue strongly that the hyperphosphorylated form of Cla4 is responsible for signaling the activation of Gin4.
Cdc42 is required for the mitosis-specific hyperphosphorylation of Gin4
The previous results suggest that Cdc42 should be required for the mitosis-specific hyperphosphorylation of Gin4. To test whether this is true, cells carrying the cdc42-1 temperature sensitive mutation were arrested in mitosis by treatment with the microtubule polymerization inhibitor benomyl. We then shifted the cells to the restrictive temperature for 2 hours in the continued presence of benomyl, and used western blotting to assay Gin4 hyperphosphorylation. We found that Gin4 hyperphosphorylation was lost at the restrictive temperature in the cdc42-1 cells, but not in wild-type control cells, as expected if Cdc42 is required for Gin4 hyperphosphorylation (Figure 5c ).
Nap1 and Cdc28, but not Gin4, are required for Cla4 hyperphosphorylation
To further delineate the requirements for Cla4 hyperphosphorylation, we assayed the ability of Clb2 ∆176 and Cdc42 V12 to induce hyperphosphorylation of Cla4 in various mutant backgrounds. We found that Cla4 hyperphosphorylation did not occur at the restrictive temperature in cells carrying a temperature-sensitive allele of the CDC28 gene, consistent with the idea that Cla4 functions in a pathway that is activated by the Clb2-Cdc28
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Figure 4
Hyperphosphorylation of Cla4 is induced by Clb2 and the GTP-bound form of Cdc42. (a) Cla4 is hyperphosphorylated in mitosis. Cells were arrested in interphase with α-factor or in mitosis with benomyl, and samples were immunoblotted with affinity-purified anti-Cla4 
Figure 5
Hyperphosphorylation of Cla4 is needed for the hyperphosphorylation of Gin4. (a) Hyperphosphorylation of Gin4 correlates with Cla4 hyperphosphorylation. The same samples used to assay Cla4 hyperphosphorylation in Figure 4b were immunoblotted with anti-Gin4 antibodies to assay for Gin4 hyperphosphorylation. (b) Cla4 is required for the Cdc42 V12 -and Clb2 ∆176 -induced activation of Gin4.
Samples from a ∆cla4 strain that overexpresses both Cdc42 V12 and Clb2 ∆176 were immunoblotted with anti-Gin4 antibodies. (c) Cdc42 is required for the mitosis-specific hyperphosphorylation of Gin4. Logphase wild-type and cdc42-1 cells were pretreated with 30 µg/ml benomyl at 23°C for 1 h before incubation at 23°C or at 37°C for an additional 2 h. Extracts made from the yeast cells were then immunoblotted with anti-Gin4 antibodies. kinase complex (Figure 6a ). We also found that Cla4 hyperphosphorylation occurs normally in ∆gin4 cells, consistent with the idea that Cla4 functions to activate the Gin4 kinase (Figure 6b ). In contrast, Cla4 hyperphosphorylation is significantly reduced in ∆nap1 cells (Figure 6c) , consistent with the genetic interactions between Nap1 and Cla4 (see Figure 2a) , and with other results demonstrating an involvement of Nap1 in the pathway used by Clb2 and Cdc28 to control bud growth during mitosis [4, 7] . As Nap1 is also required for the activation of the Gin4 kinase and we have detected a tight biochemical interaction between Gin4 and Nap1, it appears that Nap1 may have an integral role in the regulation of both Cla4 and Gin4 kinases [7] .
The in vitro kinase activity of Cla4 is not regulated by hyperphosphorylation
In previous work, it was found that Cla4 kinase activity can be detected throughout the cell cycle, and that kinase activity increases approximately sevenfold during mitosis [16] . We therefore tested whether hyperphosphorylation of Cla4 leads to changes in Cla4 kinase activity. To do this, we immunoprecipitated Cla4 from log-phase cells and from cells expressing Clb2 ∆176 and Cdc42 V12 , and then assayed kinase activity using myelin basic protein as a substrate. As controls we used strains carrying either a deletion of the CLA4 gene or a mutant version of CLA4 in which an essential lysine in the kinase active site is changed to an alanine (Cla4 K594A ). We found that the in vitro kinase activity of Cla4 is not significantly affected by the hyperphosphorylation of Cla4 (Figure 7 , compare uninduced and induced lanes). This result does not rule out the possibility that the kinase activity of Cla4 is regulated by hyperphosphorylation in vivo.
Discussion

Cla4 and Cdc42 function in a Clb2-dependent mitotic control pathway
A variety of biochemical and genetic experiments demonstrate that Cla4 and Cdc42 function in a mitotic control pathway that includes Clb2, Cdc28, Nap1 and Gin4. First, deletion of the CLA4 gene causes an elongated bud phenotype that is nearly identical to the phenotype caused by loss of function of Clb2, Nap1 or Gin4 in cells that are dependent upon Clb2 for survival. Second, CLA4 interacts genetically with GIN4, NAP1 and the mitotic cyclins, and CDC42 interacts genetically with NAP1. Third, Cla4 is required in vivo for the mitosis-specific hyperphosphorylation of Gin4. Fourth, Cla4 hyperphosphorylation is induced in vivo by the combined activity of Clb2, Cdc28, Nap1 and the GTP-bound form of Cdc42. Finally, strong hyperphosphorylation of Cla4 can be induced by Clb2, but not by the related mitotic cyclin Clb3, demonstrating that Cla4 functions in a Clb2-specific pathway. Figure 8 
Figure 7
The in vitro kinase activity of Cla4 is not regulated by hyperphosphorylation. The Cla4 protein was immunoprecipitated from rapidly growing wild-type yeast cells and assayed for kinase activity. As controls for the specificity of the kinase assay, ∆cla4 cells or cells carrying the cla4 K594A kinase-dead mutation were used. To test whether hyperphosphorylation of Cla4 leads to activation of kinase activity, kinase assays were carried out either using cells in which Cla4 hyperphosphorylation was induced by expression of Cdc42 V12 and Clb2 ∆176 , or using uninduced control cells.
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Log phase ∆cla4 K594A Uninduced Induced genes for both Cla4 and Gin4 have a more severe phenotype than either single deletion (see Figure 2) , and Gin4 and Nap1 bind directly to each other. It seems likely that signaling events in this pathway are carried out by multiprotein complexes, and that there is cross-talk between intricate and partially redundant pathways, as has been observed for other signaling pathways [19] [20] [21] .
Previous studies on Cla4 and a related member of the PAK kinase family called Ste20 also provide strong evidence supporting the idea that Cla4 functions during mitosis. It was found that cells carrying a ste20 deletion and a temperature-sensitive allele of cla4 arrest early in mitosis with a short spindle when shifted to the restrictive temperature, consistent with the idea that Cla4 carries out mitotic functions [8] . The fact that the ∆ste20 cla4 ts cells arrest with a short spindle is also consistent with the idea that Cla4 functions with Gin4 and Nap1, as loss of function of either of these genes can also cause a prolonged delay at the short spindle stage [4, 7] . Interestingly, Cla4 and Gin4 were both identified in screens for mutations that cause lethality in combination with a double deletion of the G1 cyclin genes CLN1 and CLN2 [8, 16, 22, 23] . Although the basis for the synthetic lethality is unknown, this finding supports the idea that Gin4 and Cla4 are involved in related cell-cycle functions.
Several recent studies also support the idea that Cdc42 carries out mitotic functions. First, newly isolated mutant alleles of the CDC42 gene cause the formation of elongated buds, consistent with the idea that Cdc42 function is required during mitosis to induce the switch from polar to isotropic bud growth (K. Kozminski and D. Drubin, personal communication). The original cdc42-1 allele also produces a fraction of cells with elongated buds when crossed into the W303 strain background [8] . Second, independent genetic screens for regulators of Cdc42 and for suppressors of a mutant cdc28 allele both led to the identification of related proteins called Zds1 and Zds2. Cells carrying deletions of the genes for both Zds1 and Zds2 grow very slowly, have elongated buds, and undergo prolonged delays in early mitosis at the short spindle stage [24, 25] .
Cla4 and Ste20 show a high degree of sequence similarity and share redundant functions in vivo [8, 26, 27] . However, we observed that Gin4 activation fails to occur in ∆cla4 cells that have a wild-type copy of the STE20 gene. In addition, we have so far been unable to detect any genetic interactions between STE20 and GIN4, NAP1 or CLB2 (data not shown). Therefore, it is unlikely that Cla4 and Ste20 share redundant functions in the pathway or pathways used to control Gin4 activation and polar bud growth.
Cla4 undergoes mitosis-specific hyperphosphorylation
We found that a fraction of the total Cla4 protein present in the cell becomes hyperphosphorylated during mitosis.
As Cla4 is known to interact with the Cdc42 GTPase, we reasoned that only a fraction of Cla4 undergoes hyperphosphorylation during mitosis because hyperphosphorylation is a transient event that can only be induced by the GTP-bound form of Cdc42. Consistent with this idea, we found that coexpression of Clb2 and the GTP-bound form of Cdc42 leads to nearly quantitative hyperphosphorylation of Cla4, even in cells arrested in interphase. Two lines of evidence argue strongly that Cla4 hyperphosphorylation is a biologically relevant event with an important role in the Clb2-dependent pathway that controls polar bud growth during mitosis. First, Clb2, Cdc28 and Nap1 are all required in vivo for Cla4 hyperphosphorylation, and each of these proteins has previously been shown to function in the Clb2-dependent pathway. Second, we have so far found that Gin4 hyperphosphorylation only occurs when Cla4 becomes hyperphosphorylated, suggesting that the hyperphosphorylated form of Cla4 is responsible for signaling the hyperphosphorylation of Gin4.
We do not yet understand how hyperphosphorylation regulates Cla4 activity. Hyperphosphorylation does not appear to have any significant effect on Cla4 kinase activity in vitro, although this does not rule out the possibility that hyperphosphorylation regulates kinase activity in vivo. One possibility is that hyperphosphorylation regulates the ability of Cla4 to bind to other proteins that function in the pathway. For example, perhaps Cla4 hyperphosphorylation causes assembly of a transient complex that leads to activation of the Gin4 kinase.
The in vivo functions of the Cdc42 GTPase
Studies carried out in vitro have demonstrated that members of the PAK kinase family are activated by binding of the GTP-bound form of the Cdc42 GTPase, but not the GDP-bound form, suggesting that Cdc42 may function as an on/off switch for PAK kinases [9, 28] . It is interesting to note, however, that the GTP-bound form of Cdc42 is necessary, but not sufficient, for the induction of Cla4 hyperphosphorylation. This finding suggests that the function of Cdc42 in vivo may be more complex than simply acting as an on/off switch for the activation of protein kinases. Cdc42 has been implicated in a remarkably wide variety of cellular events, and it remains unclear how the same protein functions in so many different contexts [29, 30] . Indeed, the exact molecular role of Cdc42 in vivo remains unclear. One interesting possibility is that Cdc42 functions to monitor the specificity of signaling reactions by linking multiprotein complex formation and/or phosphorylation events to GTP hydrolysis.
The role of Cla4 in the control of cell-cycle events
Cla4 is required in vivo for the mitosis-specific activation of the Gin4 kinase, and for the proper control of bud growth during mitosis. In addition, loss of Cla4 function in ∆ste20 cells causes an arrest at the short spindle stage. It is unclear at present why loss of function of Cla4, Gin4 or Nap1 can cause prolonged mitotic delays at the short spindle stage, although there are a number of interesting possibilities. One possible explanation is that these proteins are directly involved in aspects of mitotic spindle assembly, and loss of function causes cells to have difficulty assembling a functional mitotic spindle. Another possibility is that these proteins are primarily involved in a pathway that controls bud growth during mitosis, and defects in this pathway activate a checkpoint that arrests the nuclear cycle at the short spindle stage. A third possibility is that Cla4, Gin4 and Nap1 are part of a checkpoint pathway that normally functions during mitosis to inactivate a negative regulator of the cell cycle when mitotic events are occurring properly. Loss of function of such a pathway would result in a failure to inactivate the inhibitor, which would lead to a mitotic delay. A final possibility is that Cla4, Nap1 and Gin4 function in a pathway that triggers the destruction of mitotic cyclins or other proteins that must be destroyed before cells can exit mitosis. These various possibilities are not mutually exclusive. For example, studies on the DNA damage checkpoint have demonstrated that proteins involved in carrying out specific cell-cycle events can also be involved in checkpoints that detect when cell-cycle events have not occurred properly [31, 32] .
Control of cell-cycle events by cyclin-dependent kinases
The mechanisms used by cyclin-dependent kinases to induce and coordinate the events of the cell cycle are largely unknown. For example, it remains unclear whether cyclin-dependent kinases directly phosphorylate proteins involved in cell-cycle events, or whether they activate intricate signaling pathways that ultimately regulate the proteins directly involved in cell-cycle events.
Given the complexity of cell-cycle events and the fact that they must be precisely controlled, it would not be unexpected to find that they are regulated by intricate signaling pathways.
We have found that Cla4 and Cdc42 have critical roles in a pathway used by the Clb2-Cdc28 cyclin-dependent kinase complex to control certain mitotic events. We also found that Nap1, the Clb2-Cdc28 kinase complex and the GTP-bound form of Cdc42 work together to induce hyperphosphorylation of Cla4, and that Cla4 is required for the mitosis-specific activation of the Gin4 kinase. These results show that the Clb2-Cdc28 kinase complex controls specific events of mitosis through a GTPaselinked signaling mechanism. It seems possible that cyclindependent kinases may control many other cell-cycle events by activating complex signaling cascades rather than by directly phosphorylating proteins involved in specific events. Additional genetic and biochemical studies should lead to the identification of more proteins that function in the Clb2-dependent mitotic control pathway, as well as to an understanding of the molecular mechanisms underlying the mitosis-specific regulation of the Cla4 and Gin4 kinases. 
Materials and methods
Strains used in this study
Cloning and deletion of the CLA4 gene
We cloned the CLA4 gene by complementation using a genomic library carried in a CEN plasmid. The cloning was aided by the fact that the original mutant allele identified in our genetic screen is hypersensitive to hydroxyurea. After transforming mutant cells with the plasmid library, we were therefore able to grow cells on plates containing 5 mg/ml hydroxyurea, which strongly inhibited the growth of mutant cells without significantly affecting the growth of wild-type cells. Cells carrying the NAP1 deletion are also hydroxyurea sensitive (D. Kellogg, unpublished observations). The original mutation segregates 2:2 with a deletion of the CLA4 gene, demonstrating that the mutation lies in the CLA4 gene.
To delete the CLA4 gene, we used PCR to amplify the URA gene from the pRS306 vector with 60 bases of homology to the 5′ and 3′ ends of the CLA4 open reading frame on each end (primers: ATGTCTCTTTC-AGCTGCAGCGAATAAGATATCTGACAACGATTTCCAAAATATCG GACCGGCCGGCATCAGAGCAGATTGTAC and TCATTCCTT-CCACTCCAACAGTGATGTCAAATCCTTTGGATCACATGCCATATT GAAAAAACCGTCCTTACGCATCTGTGCGGTAT). The resulting PCR product was transformed into strain DK186 or DK212, and cells carrying the CLA4 deletion were identified by PCR and confirmed by western blotting.
Overexpression of Clb2 ∆176 and Cdc42 V12
To create plasmids that express Clb2 ∆176 and Cdc42 V12 we used the plasmid pDK20, which carries the bidirectional GAL1/10 promoter cloned into the KpnI and XhoI sites of pRS306. A plasmid that expresses Cdc42 V12 under the control of the GAL10 promoter was constructed by cloning the DNA encoding Cdc42 V12 into the GAL10 side of the promoter (pHT26), and a plasmid that expresses Clb2 ∆176 under the control of the GAL1 promoter was constructed by cloning the DNA encoding Clb2 ∆176 into the GAL1 side of the promoter (pAR39-1, gift of Adam Rudner). To construct a plasmid that expresses both proteins, Clb2 ∆176 and Cdc42 V12 were cloned into pDK20 together into the same sites described above. Plasmids that express wild-type Cdc42 and Clb2 ∆176 , or Cdc42 V12 and Clb3 were constructed in the same manner (pHT28 and pDK59, respectively). All plasmids were integrated at the URA3 gene.
To induce expression of proteins, yeast cells were grown overnight at room temperature to an OD 600 of 0.5-0.6 in YEP media containing 2% glycerol and 2% ethanol. The cells were arrested in interphase by addition of α-factor to 2 µg/ml, followed by incubation at 30°C for 2 h. Expression of proteins was then induced by the addition of galactose to 2%, and 1.6 ml samples are taken at the indicated times. Samples were prepared for electrophoresis and western blotting as previously described [7] .
Cell-cycle arrests and detection of proteins
Cell-cycle arrests and preparation of samples for gel electrophoresis and western blotting were carried out as previously described [7] . To resolve differently phosphorylated forms of Cla4, we electrophoresed samples through 10% polyacrylamide gels (6.5 by 14.0 cm) for 3 h at 185 V [33] . To detect Cla4, we used an affinity-purified rabbit polyclonal antibody raised against a glutathione-S-transferase (GST) fusion protein that includes amino acids 140-511 of the Cla4 protein. Gin4 hyperphosphorylation was assayed as previously described [7] . For the experiment shown in Figure 5c , cells carrying the cdc42-1 allele were incubated in the presence of 30 µg/ml benomyl in YPD media at room temperature for 1 h before shifting to the restrictive temperature of 37°C for 2 h.
Treatment of Cla4 with phosphatase
Cla4 was immunoprecipitated from cells expressing Clb2 ∆176 and Cdc42 V12 and treated with lambda phosphatase (New England Biolabs) as previously described for Gin4 [7] .
Construction of a Cla4 kinase domain mutant and Cla4 kinase assays
To generate a catalytically inactive mutant version of Cla4, two PCR reactions were carried out to amplify the 5′ and 3′ ends of the open reading frame, overlapping by 20 base pairs. The first oligo pair was GCGGAATTCGTATCATCAGACAGTAACTCC (Cla4-33) and GATAGCAACTTTATCTCCTA (Cla4-38), while the second pair was GAGATAAAGTTGCTATCGCGCAAATGGTCTTATCTAAAC (Cla4-35) and GCGCAAGCTTTCATTCCTTCCACTCCAACAG (Cla4-37). The Cla4-35 oligo incorporates two mismatched bases that change the conserved lysine in subdomain II to an alanine. The products of these two reactions were gel purified, mixed together, and used as a template for a PCR reaction with primers Cla4-33 and Cla4-37 to generate a full-length fragment that incorporates the mutation, which was cloned into the vector YIplac211. The resulting vector (pDM2) was digested with AvrII to target integration at the CLA4 gene, and transformants were grown in the presence of 5-fluoro-orotic acid to select for recombination events between the duplicated CLA4 sequences that loop out the URA3 gene. Recombination events that leave the mutation in the genomic copy of Cla4 were identified by PCR. This procedure was carried out with two different plasmid isolates, both of which gave the same results.
To assay Cla4 kinase activity, the cells from 15 ml of culture at an OD 600 of 0.7 were harvested and frozen on liquid nitrogen. Cla4 was then immunoprecipitated and assayed as previously described for Gin4 kinase assays, except that 2.5 µg myelin basic protein was used as a substrate for each assay [7] .
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